RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+8.88%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.2B
AUM Growth
+$4.2B
(+0.35%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
34.34%
Holding
127
New
6
Increased
35
Reduced
17
Closed
3
Top Buys
| 1 |
Humana
HUM
|
$19.5M |
| 2 |
Boston Scientific
BSX
|
$14.5M |
| 3 |
Merus
MRUS
|
$12.6M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$9.71M |
| 5 |
Agilon Health
AGL
|
$6.94M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.2% |
| 2 | Consumer Staples | 1.04% |
| 3 | Industrials | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABCM
26
DELISTED
Abcam plc American Depositary Shares
ABCM
| $58.9M | 1.4% | 2,405,000 +162,500 | +7% | +$3.98M |
|
27
Prothena Corp
PRTA
$441M
| $51.4M | 1.22% | 753,462 | – | – |
|
|
HZNP
28
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $50.9M | 1.21% | 495,000 -245,100 | -33% | -$25.2M |
|
29
Sarepta Therapeutics
SRPT
$1.78B
| $48.7M | 1.16% | 425,000 -17,500 | -4% | -$2M |
|
30
Mirum Pharmaceuticals
MIRM
$3.71B
| $47.1M | 1.12% | 1,820,733 +25,000 | +1% | +$647K |
|
31
Madrigal Pharmaceuticals
MDGL
$9.76B
| $46M | 1.09% | 199,218 -148,903 | -43% | -$34.4M |
|
32
Xenon Pharmaceuticals
XENE
$2.98B
| $45.4M | 1.08% | 1,178,002 | – | – |
|
33
Freshpet
FRPT
$2.72B
| $43.6M | 1.04% | 662,500 | – | – |
|
34
Pacira BioSciences
PCRX
$1.2B
| $41.5M | 0.99% | 1,035,000 +2,400 | +0.2% | +$96.2K |
|
35
Aclaris Therapeutics
ACRS
$209M
| $41.1M | 0.98% | 3,961,849 | – | – |
|
|
MRTX
36
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $40.5M | 0.96% | 1,121,647 +56,386 | +5% | +$2.04M |
|
37
Phreesia
PHR
$1.88B
| $40.5M | 0.96% | 1,305,000 +2,500 | +0.2% | +$77.5K |
|
|
ACCD
38
DELISTED
Accolade, Inc. Common Stock
ACCD
| $38M | 0.9% | 2,820,000 +275,000 | +11% | +$3.7M |
|
39
Ascendis Pharma
ASND
$11.8B
| $38M | 0.9% | 425,500 | – | – |
|
40
Kymera Therapeutics
KYMR
$2.95B
| $34.2M | 0.81% | 1,487,551 +259,172 | +21% | +$5.96M |
|
41
Zai Lab
ZLAB
$3.68B
| $33.9M | 0.81% | 1,222,423 +162,723 | +15% | +$4.51M |
|
42
Amylyx Pharmaceuticals
AMLX
$836M
| $33.3M | 0.79% | 1,544,616 +91,800 | +6% | +$1.98M |
|
|
SWAV
43
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $32.9M | 0.78% | 115,100 | – | – |
|
44
iRhythm Technologies
IRTC
$5.46B
| $32.3M | 0.77% | 309,450 | – | – |
|
45
Legend Biotech
LEGN
$6.41B
| $31.6M | 0.75% | 458,265 | – | – |
|
|
OLK
46
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $31M | 0.74% | 1,654,000 +4,000 | +0.2% | +$75K |
|
|
NVRO
47
DELISTED
NEVRO CORP.
NVRO
| $30.8M | 0.73% | 1,211,400 +133,500 | +12% | +$3.39M |
|
48
Immatics
IMTX
$619M
| $29.3M | 0.7% | 2,536,144 +22,221 | +0.9% | +$256K |
|
49
CONMED
CNMD
$1.68B
| $27.9M | 0.66% | 205,000 | – | – |
|
50
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $26.5M | 0.63% | 200,000 | – | – |
|